Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • MESH
  • Antiretroviral Therapy, Highly Active
  • HIV
  • HIV Infections
  • Humans
  • Male
  • Semen

Unbound MEDLINE

Prevention. HIV still evident in semen of men receiving HAART.

Source

AIDS policy & law 27:6 2012 May pg 1

MeSH

Antiretroviral Therapy, Highly Active
HIV
HIV Infections
Humans
Male
Semen

Pub Type(s)

Newspaper Article

Language

eng

PubMed ID

22655312

Related Citations

  • Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
  • Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.
  • Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).
  • No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002-2009 survey.
  • Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
  • Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
  • Effect of antiretroviral therapy on HIV shedding in semen.
  • HAART won't completely eradicate HIV in semen.
More
unbound logo
  • Home »
  • Contact Us »
  • Help »
  • Privacy / Disclaimer »
  • Terms of Service »
  • Log In »
  • twitter
  • facebook
© 2000–2013 Unbound Medicine, Inc. All rights reserved